AbnormalGAN Simulating Pathologies for Rare Disease Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Deep learning models, specifically DCNNs, face challenges in performing well across different patients due to class imbalance issues, particularly with rare pathologies, leading to suboptimal performance in detecting life-saving diseases.

Innovation Solution

The AbnormalGAN framework uses generative adversarial networks to simulate pathological tissues on healthy patients' scans, increasing the dataset with artificially generated abnormalities, thereby addressing data imbalance and enhancing model performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If deep convolutional neural networks are trained with limited data for rare pathologies, then training time and computational resources are reduced, but detection accuracy and model performance deteriorate

Engineering Contradiction:
Improvetraining efficiencyVSAvoiddetection accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent uses generative adversarial networks to create synthetic copies of medical images with rare pathologies. The GAN framework generates realistic-looking images that replicate the appearance and characteristics of actual pathological cases, providing abundant training data without requiring additional real patient scans. This copying approach resolves the contradiction by supplying sufficient training examples for rare conditions while avoiding the need for extensive data collection or prolonged training with limited samples.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent transforms the training data landscape by changing the parameter of data availability through synthetic generation. By adjusting the GAN training parameters and generation processes, the system produces varied synthetic images with different pathological presentations, effectively expanding the training dataset size and diversity. This parameter change enables the model to achieve high detection accuracy for rare pathologies without the constraint of limited real-world data samples.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If more training images are collected to improve performance on rare pathologies, then detection accuracy improves, but data collection time and storage requirements increase

Engineering Contradiction:
Improvedetection accuracyVSAvoiddata collection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

Instead of collecting additional real medical images through time-consuming data acquisition processes, the patent employs GANs to generate synthetic copies of pathological images. These synthesized images replicate the visual characteristics and diagnostic features of rare conditions, providing充足的 training data without requiring extended data collection efforts from hospitals and medical institutions.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent performs preliminary data preparation by pre-training GAN models on available medical image datasets before deploying them for generating rare pathology samples. This preliminary action creates a ready-to-use synthetic data generation system that can quickly produce training images on demand, eliminating the need for time-intensive real-time data collection and preprocessing during model development.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If deep learning models are trained to recognize rare pathologies, then early detection capability improves, but model complexity and training data requirements increase

Engineering Contradiction:
Improveearly detection capabilityVSAvoidmodel complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses synthetic image copying through GANs to provide comprehensive training examples for rare pathologies without requiring the model to become overly complex. The generated images cover various presentations and variations of rare conditions, enabling the model to learn robust detection patterns while maintaining reasonable architectural complexity. This approach improves early detection reliability without proportionally increasing model complexity.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent develops a universal GAN-based framework that can generate synthetic images for multiple types of rare pathologies across different medical imaging modalities. This multi-functional system serves various detection tasks simultaneously, reducing the need for separate complex models for each rare condition. The universal approach improves early detection capability across multiple disease types while keeping individual model complexities manageable through shared generative architecture.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11854703B2Simulating abnormalities in medical images with generative adversarial networks
Publication Date: 2023.12.26 ARTERYS INC
  • US11854703B2 patent drawing
  • US11854703B2 patent drawing
  • US11854703B2 patent drawing

AI summary

Systems and methods for providing a novel framework to simulate the appearance of pathology on patients who otherwise lack that pathology. The systems and methods include a “simulator” that is a generative adversarial network (GAN). Rather than generating images from scratch, the systems and methods discussed herein simulate the addition of diseases-like appearance on existing scans of healthy patients. Focusing on simulating added abnormalities, as opposed to simulating an entire image, significantly reduces the difficulty of training GANs and produces results that more closely resemble actual, unmodified images. In at least some implementations, multiple GANs are used to simulate pathological tissues on scans of healthy patients to artificially increase the amount of available scans with abnormalities to address the issue of data imbalance with rare pathologies.